Angioimmunoblastic-like T-cell non Hodgkin's lymphoma: Outcome after chemotherapy in 33 patients and review of the literature

Leukemia and Lymphoma

Volumn 32, Issue 5-6, 1999, Pages 545-552

  Pautier, Patricia ^a,b   Devidas, Alain ^a,c   Delmer, Alain ^a,d   Dombret, Herve ^a,b   Sutton, Laurent ^a,e   Zini, Jean Marc ^a,f   Nedelec, Gerard ^a,g   Molina, Thierry ^a,d   Marolleau, Jean Pierre ^a,b   Brice, Pauline ^a,b  

^a Club de Reflexion en Hematologie   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c Hôpital de Corbeil   (France)

^d HÔTEL DIEU   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f HÔPITAL LARIBOISIÈRE   (France)

^g University of Paris Descartes   (France)

Author keywords

Angioimmunoblastic T cell lymphomal; Chemotherapy; High dose chemotherapy; Interferon

Indexed keywords

ALPHA INTERFERON; ANTHRACYCLINE; ANTINEOPLASTIC AGENT; BLEOMYCIN; CHLORAMBUCIL; CISPLATIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; LACTATE DEHYDROGENASE; PREDNISONE; STEROID; VINCRISTINE; VINDESINE;

ADOLESCENT; ADULT; ANEMIA; ANGIOIMMUNOBLASTIC LYMPHADENOPATHY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; HYPEREOSINOPHILIA; HYPERGAMMAGLOBULINEMIA; LACTATE DEHYDROGENASE BLOOD LEVEL; LYMPHOCYTOPENIA; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 0032977114     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199909058412     Document Type: Article

References (28)

1. Brice, P., Calvo, F., D'Agay, M. F., Gisselbrecht, C., Valensi, F., Trédaniel, J., Boiron, M., Flandrin, G. (1987) Peripheral T-cell lymphoma following angioimmunoblastic lymphadenopathy. Nouvelle revue Française d'hématologie, 29, 371-377.
2. Ganesan, T. S., Dhaliwal, H. S., Dorreen, M. S., Stansfeld, A. G., Habeshaw, J. A., Lister, T. A. (1987) Angioimmunoblastic lymphadenopathy: a clinical, immunological and molecular study. British Journal of Cancer, 55, 437-442.
3. Liang, R., Todd, D., Chan, T. K., Wong, K. L., Ho, F., Lake, S. L. (1987) Peripheral T-cell lymphoma. Journal of Clinical Oncology, 5, 750.
4. Steinberg, A. D., Seldin, M., Jaffe, E. S., Smith, H. R., Klinman, D. M., Krieg, A. M., Cossman, J. (1988) Angioimmunoblastic lymphadenopathy with dysproteinemia. (NIH conference). Annals of Internal Medicine, 108, 575-584.
5. Tobinai, K., Minato, K., Ohtus, T., Mukai, K., Kagami, Y., Miwa, M., Watanabe, S., Shimoyama, M. (1988) Clinicopathologic, immunophenotypic and immunogenotypic analyses of immunoblastic lymphadenopathy-like T-cell lymphoma. Blood, 72, 1000-1006.
6. Kaneko, Y., Maseki, N., Sakurai, M., Takayama, S., Namba, K., Kikuchi, M., Frizzera, G. (1988) Characteristic karyotypic pattern in T-cell lymphoproliferative disorders with reactive "angioimmunoblastic lymphadenopathy with dysproteinemia-type" features. Blood, 72, 413-421.
7. Schlegelberger, B., Zhang, Y., Weber-Matthiesen, K., Grote, W. (1994) Detection of aberrant clones in nearly all cases of angioimmunoblastic lymphadenopathy with dysproteinemia type T-cell lymphoma by combined interphase and metaphase. Blood, 84, 2640-2648.
8. Araki, A., Taniguchi, M., Mikata, A. (1994) T cell receptor Vβ repertoires of angioimmunoblastic lymphoadenopathy-like T cell lymphoma. Leukemia Lymphoma, 16, 135-140.
9. Anagnostopoulos, I., Hummel, M., Finn, T., Tiemann, M., Korbjuhn, P., Dimmler, C., Gatter, K., Dallenbach, F., Parwaresch, M. R., Stein, H. (1992) Heterogeneous Epstein-Barr virus infection patterns in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type. Blood, 80, 1804-1812.
10. Ohshima, K., Takeo, H., Kikuchi, M., Kozuru, M., Uike, N., Masuda, Y., Yoneda, S., Takeshita, M., Shibata, T., Akamatsu, M. (1994) Heterogeneity of Epstein-Barr virus infection in angioimmunoblastic lymphadenopathy type T-cell lymphoma. Histopathology, 25, 569-579.
11. Foss, H. D., Anagnostopoulos, I., Herbst, H., Grebe, M., Ziemann, K., Hummel, M., Stein, H. (1995) Patterns of cytokine gene expression in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type. Blood, 85, 2862-2869.
12. Harris, N.L., Jaffe, E. S., Stein, H., Banks, P. M., Chan, J. K., Cleary, M. L., Delsol, G., De Wolfpeeters, C., Falini, B., Gatter, K. C. (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood, 84, 1361-1392.
13. Hiddemann, W., Longo, D. L., Coiffier, B., Fisher, R. I., Cabanillas, F., Cavalli, F., Nadler, L. M., De Vita, V. T., Armitage, J. O. Lymphoma classification-The gap between biology and clinical management is closing. Blood, 88, 4085-4089.
14. Pangalis, G. A., Moran, E. M., Nathwani, B. H., Zeldman, R. J., Kim, H. Rappaport H. (1983) Angioimmunoblastic lymphadenopathy. Long-term follow-up study. Cancer, 52, 318-321.
15. Archimbaud, E., Coiffier, B., Bryon, P. A., Vasselon, C., Brizard, C. P., Viala, J. J. (1987) Prognostic factors in angioimmunoblastic lymphadenopathy. Cancer, 59, 208-212.
16. Nathwani, B. N., Rappaport, H., Moran, E. M., Pangalis, G. A., Kim, H. (1978) Malignant lymphoma arising in angioimmunoblastic lymphadenopathy. Cancer, 41, 578-606.
17. Siegert, W., Agathe, A., Griesser, H., Schwerdtfeger, R., Britinger, G., Engelhard, M., Kuse, R., Tiemann, M., Lennert, K., Huhn, D. (1992) Treatment of angioimmunoblastic lymphadenopathy (AILD) type T-cell lymphoma using prednisone with or without the COPBLAM/IMVP16 regimen. Annuals of Internal Medcine, 117, 364-370.
18. Kaplan, E. S., Meier, P. (1958) Non parametric estimation from incomplete observations. Journal of American Statistics Association, 53, 457-461.
19. Schlegelberger, B., Zwingers, T., Hohenadel, K., Henne-Bruns, D., Schmitz, N., Haferlach, T., Tirier, C., Bartels, H., Sonnen, R., Kuse, R., Grote, W. (1996) Significance of cytogenetic findings for the clinical outcome in patients with T-cell lymphoma of angioimmunoblastic lymphadenopathy type. Journal of Clinical Oncology, 14, 593-599.
20. Shipp, M. A. (1994) Prognostic factors in aggressive non-Hodgkin's lymphoma: who has high-risk disease. Blood, 83, 1165-1173.
21. Coiffier, B., Brousse, N., Peuchmaur, M., Berger, F., Gisselbrecht, C., Bryon, P. A., Diebold, J. (1990) Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas. Annals of Oncology, 1, 45-50.
22. Coupland, R. W., Pontifex, A. H., Salinas, F. A. (1985) Angioimmunoblastic lymphadenopathy with dysproteinemia: circulating immune complexes and the review of 18 cases. Cancer, 55, 1902-1906.
23. Watanabe, S., Sato, Y., Shimoyama, M., Minato, K., Shimosato, Y. (1986) Immunoblastic lymphadenopathy, angioimmunoblastic lymphadenopathy, and IBL-like T-cell lymphoma. Cancer, 58, 2224-2232.
24. Armitage, J. O. (1993) Treatment of non-Hodgkin's lymphoma. New England Journal of Medicine, 328, 1023-1030.
25. Philip, T., Guglielm, C., Hagenbeck, A., Somers, R., Van der Lelie, H., Bron, D., Sonneveld, P., Gisselbrecht, C., Cahn, J. Y., Harousseau, J. L. (1995) Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non Hodgkin's lymphoma. New England Journal of Medicine, 333, 1540-1545.
26. Siegert, W., Nerl, C., Meuthen, I., Zahn, T., Brack, N., Lennert, K., Huhn, D.(1991) Recombinant human interferon α in the treatment of angioimmunoblastic lymphadenopathy: results in 12 patients. Leukemia, 5, 892-895.
27. Rohatiner, A. Z. S. (1991) Interferon alpha in lymphoma. British Journal of Hematology, 79, 26-29.
28. Gisselbrecht, C., Gaulard, P., Lepage, E., Coiffier, B., Briere, J., Haioun, C., Cazals, D., Diebold, J. (1996) Prognostic significance of T-cell phenotype in aggressive non Hodgkin's lymphoma. Blood, 88, suppl. 1 : 1159.